Tag Archives: MissionIR
MissionIR News – VistaGen Therapeutics Enters Into Strategic Research Collaboration with Duke University
Atlanta, GA (PRWEB) March 06, 2012 MissionIR would like to highlight VistaGen Therapeutics, Inc. (OTCBB: VSTA), focused on applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to … Continue reading
MissionIR News – EDGAR Online Posts Q4, Full-year Financial Results
Atlanta, GA (PRWEB) March 03, 2012 MissionIR would like to highlight EDGAR
MissionIR News – FluoroPharma Medical First in Class Diagnostic Agent Advanced to Phase II Study
Atlanta, GA (PRWEB) March 02, 2012 MissionIR would like to highlight FluoroPharma (OTCBB: FPMI), a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate disease at the cellular and molecular levels. The company has … Continue reading
MissionIR News – GlobalWise Investments Subsidiary Emerges as Leading-Edge Cloud Technology Company
Atlanta, GA (PRWEB) February 29, 2012 MissionIR would like to highlight GlobalWise Investments, Inc. (OTCBB: GWIV). The company, via its wholly owned subsidiary Intellinetics, Inc., is a Columbus, Ohio, based Enterprise Content Management (ECM) pioneer with industry-leading software that delivers … Continue reading